Decrease of diffusion of glycosylated albumin in retinal microcirculation by peptide fraction from bovine factor VIII

Area of Science:

• Ophthalmology
• Vascular Biology
• Pharmacology

Background:

• Retinal vascular damage is a complication of various systemic diseases.
• Glycosylated albumin can leak into the retinal vasculature, contributing to damage.
• Understanding factors influencing this diffusion is crucial for therapeutic development.

Purpose of the Study:

• To investigate the effect of a peptide fraction from bovine Factor VIII (Vueffe) on glycosylated albumin diffusion in the retinal vascular system.
• To evaluate the potential of Vueffe as a therapeutic agent for retinal vascular damage.

Main Methods:

• Male New Zealand rabbits were divided into two groups: one treated with Vueffe and a control group receiving physiological solution for 15 days.
• After treatment, fluorescently labeled glycosylated albumin was injected intravenously.
• Retinal capillary diffusion was assessed using fluorangiographic techniques, direct observation, and photometric measurements on digitized images.

Main Results:

• Animals treated with the peptide fraction (Vueffe) exhibited a significant reduction in retinal capillary diffusion of glycosylated albumin compared to the control group.
• Photometric analysis of digitized fluorangiograms confirmed this reduction in vascular leakage.

Conclusions:

• The peptide fraction from bovine Factor VIII (Vueffe) demonstrates a capacity to decrease glycosylated albumin diffusion in the retinal vasculature.
• Vueffe may hold promise as a therapeutic intervention for managing retinal vascular damage associated with systemic diseases.